TITLE:
A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

CONDITION:
Major Depressive Disorder

INTERVENTION:
Antidepressant + Aripiprazole

SUMMARY:

      This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in
      outpatients with major depressive disorder who have experienced an incomplete response to an
      ongoing antidepressant trial.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Men and women, 18 years or older

          -  Experiencing Major Depressive Disorder with a duration of minimally 8 weeks.

          -  Treatment history of an inadequate response to at least one and no more than four
             antidepressants
      
